Timboligue, Bernadette M.

HRN: 28-56-04  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/03/2026
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
03/03/2026
03/10/2026
IV
4.5g
Q8
Cholecystitis, Renal Parenchymal Disease
Checking Initial Appropriateness 

 Indication:  Empiric    Type of Infection:  Intra-abdominal    Compliance to guidelines: Compliant To Guidelines